Related Experiment Video
Updated: Mar 29, 2026
A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
Published on: April 10, 2014
[INFLUENCE OF 29-40 AND 65-76 MCP-1 FRAGMENTS ON MYOCARDIUM MORPHOLOGY IN RATS AFTER T9CTHFMIA-R'FPFRFTTON]
Abstract:
Monocyte chemotactic protein-1 (MCP-1) is a chemokine that stimulates monocytes and macrophage migration into the sites of acute of chronic inflammation. Our study shows morphological changes in ischemic myocardium followed by the administration of two synthetic structural fragments of MCP-1 that are monocyte/macrophage migration inductor peptide IX and peptide X an inhibitor. Results show that peptides can change time points of the inflammatory response in myocardium. Peptide IX administration leads to increased and accelerated inflammatory response, i. e. attracts an additional number of monocytes and macrophages into the inflammatory focus. The introduction of the peptide X observed prolonged inflammatory process with the overall gain signs of myocardial damage.
Insights
Monocyte chemotactic protein-1 (MCP-1) synthetic fragments alter myocardial inflammation. Peptide IX accelerates monocyte/macrophage infiltration, while Peptide X prolongs inflammation and myocardial damage.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Context:
- Monocyte chemotactic protein-1 (MCP-1) is a key chemokine in inflammatory responses.
- Myocardial ischemia triggers inflammatory processes involving monocyte and macrophage infiltration.
- Understanding MCP-1's role is crucial for developing targeted therapies for heart disease.
Purpose:
- To investigate the effects of synthetic MCP-1 fragments on inflammatory responses in ischemic myocardium.
- To evaluate the distinct impacts of a monocyte/macrophage migration inductor (Peptide IX) and an inhibitor (Peptide X) on myocardial inflammation.
Summary:
- Administration of synthetic MCP-1 fragments, Peptide IX and Peptide X, induced morphological changes in ischemic myocardium.
- Peptide IX enhanced and accelerated the inflammatory response by increasing monocyte and macrophage recruitment to the site of injury.
- Peptide X resulted in a prolonged inflammatory process, exacerbating myocardial damage.
Impact:
- These findings highlight the potential of MCP-1 fragments in modulating inflammatory timelines during myocardial ischemia.
- The study suggests that Peptide IX could amplify acute inflammatory responses, while Peptide X may prolong chronic inflammation.
- This research provides insights into targeted therapeutic strategies for managing inflammation in ischemic heart conditions.
